Wednesday, January 14, 2026

CATEGORY

AOTMiT

Edwards Lifesciences’ SAPIEN 3 Ultra RESILIA Valve Shows Exceptional One-Year Outcomes

Edwards Lifesciences has unveiled promising one-year data for its latest SAPIEN 3 Ultra RESILIA valve at PCR London Valves 2024. The findings, also featured...

IECS Launches Adaptive Health Technology Evaluation to Enhance Resource Allocation

Argentina's Instituto de Efectividad Clínica y Sanitaria (IECS) is at the forefront of optimizing healthcare resources by introducing the Adaptive Health Technology Assessment (ATHA)....

AOTMiT President Endorses Amvuttra for Hereditary Transthyretin Amyloidosis Treatment

The President of the Agency for Health Technology Assessment and Tariff System issued Recommendation No. 123/2024 on November 12, 2024, endorsing the drug Amvuttra...

AOTMiT President Endorses Abrysvo Vaccine for Infant RSV Protection

The President of the Agency for Health Technology Assessment and Tariff System has officially recommended the approval of Abrysvo, a bivalent recombinant vaccine, for...

Latest news